These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9701099

  • 21. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
    Sieg A, Sellinger M, Schlauch D, Hörner M, Fuchs W.
    Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M, Asaka M, Kudoh M, Kagaya H, Katagiri M, Takeda H.
    J Clin Gastroenterol; 1995 Jul; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [Abstract] [Full Text] [Related]

  • 23. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
    O'Morain C, Dettmer A, Rambow A, von Fritsch E, Fraser AG.
    Helicobacter; 1996 Sep 26; 1(3):130-7. PubMed ID: 9398893
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T, Ido K, Taniguchi Y, Satoh K, Saifuku K, Kihira K, Yoshida Y, Kimura K.
    J Clin Gastroenterol; 1995 Sep 26; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [Abstract] [Full Text] [Related]

  • 28. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
    Bhasin DK, Sharma BC, Ray P, Pathak CM, Singh K.
    Helicobacter; 2000 Jun 26; 5(2):84-7. PubMed ID: 10849056
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
    Niv Y.
    Dig Dis Sci; 2005 May 26; 50(5):839-41. PubMed ID: 15906754
    [Abstract] [Full Text] [Related]

  • 31. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.
    Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larkö A, Wrangstadh M.
    Eur J Gastroenterol Hepatol; 2001 Dec 26; 13(12):1457-65. PubMed ID: 11742194
    [Abstract] [Full Text] [Related]

  • 32. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
    Lai YC, Wang TH, Huang SH, Yang SS, Wu CH, Chen TK, Lee CL.
    World J Gastroenterol; 2003 Jul 26; 9(7):1537-40. PubMed ID: 12854158
    [Abstract] [Full Text] [Related]

  • 33. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A, Ahuja V, Bal CS, Das B, Pandey RM, Sharma MP.
    Helicobacter; 2004 Apr 26; 9(2):124-9. PubMed ID: 15068413
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
    Kato S, Ritsuno H, Ohnuma K, Iinuma K, Sugiyama T, Asaka M.
    Helicobacter; 1998 Dec 26; 3(4):278-82. PubMed ID: 9844069
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H, Yamada T, Sato K, Ohta K, Ohkura R, Murai T, Nagahara A, Takei Y, Ogihara T, Sato N.
    Dig Dis Sci; 2000 Jan 26; 45(1):77-82. PubMed ID: 10695617
    [Abstract] [Full Text] [Related]

  • 37. Dual versus triple therapy in eradication of Helicobacter pylori.
    Ohlin B, Cederberg A, Kjellin T, Kullman E, Melén K, von Holstein CS, Thoring M.
    Hepatogastroenterology; 2002 Jan 26; 49(43):172-5. PubMed ID: 11941946
    [Abstract] [Full Text] [Related]

  • 38. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin.
    Jaup BK.
    Helicobacter; 1996 Dec 26; 1(4):260-1. PubMed ID: 9398878
    [No Abstract] [Full Text] [Related]

  • 39. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M, Székely E, Illyés G, Széles I.
    Orv Hetil; 2000 Jul 30; 141(31):1711-4. PubMed ID: 10976194
    [Abstract] [Full Text] [Related]

  • 40. Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
    Isomoto H, Inoue K, Furusu H, Nishiyama H, Shikuwa S, Omagari K, Mizuta Y, Murase K, Murata I, Kohno S.
    Helicobacter; 2003 Apr 30; 8(2):111-9. PubMed ID: 12662378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.